Novaltransit Stop+
Food supplement declared in France, declaration No 2022-6-526, decision dated 8 June 2022
Novaltransit Stop+ is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- not provided
- Food business operator placing the product on the market
- NOVALTUREL
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Gélule
- Daily dose
- 1 gélule
- Directions for use
- 1 gélule par jour le matin à jeun
Declaration 318681, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
None of the rules we check applies to the declared ingredients.
Declared composition
Micro-organisms
| Strain | Per day |
|---|---|
| Lactobacillus Plantarum LP01 | 12,500,000,000 (unit not declared) |
| Lactobacillus Rhamnosus LR06 | 12,500,000,000 (unit not declared) |
| Lactobacillus Reuteri LE02 | 12,500,000,000 (unit not declared) |
| Lactobacillus Acidophilus LA02 | 12,500,000,000 (unit not declared) |
| Bifidobacterium Longum BL03 | 12,500,000,000 (unit not declared) |
| Bifidobacterium Bifidum BB01 | 12,500,000,000 (unit not declared) |
| Bifidobacterium Infantis BIO2 | 12,500,000,000 (unit not declared) |
| Lactococcus Lactis CBTSL6 | 12,500,000,000 (unit not declared) |
Additives
Hydroxypropyl Méthyl Cellulose, E414
Other ingredients
Extrait de riz
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.